Researchers have found a new device that allows for 3-D molecular breast images at higher resolution than current 2-D scans while cutting down the radiation dosages. The new device called variable angle slant hole collimator or VASH collimator replaces a component in existing molecular breast imagers. The findings showed that the VASH collimator may enable existing breast cancer imagers to provide up to six times better contrast of tumours in the breast while maintaining the same or better image quality. Further the device will also present the precise location (depth information) of the tumour within the breast and significantly reduce
